Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Helen Kaye Quillin has worked on the following 7 EPO patent applications which have been published in the last five years:

EP10824199

HBV ANTISENSE INHIBITORS

IPC classification:
A61K 31/7115, A61K 31/7125, A61P 1/16, A61P 31/20
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12842012

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

IPC classification:
C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12842273

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

IPC classification:
A61K 31/535
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP12840924

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

IPC classification:
C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14761064

THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDES AND ANALOGUES AS SIRTUIN MODULATORS

IPC classification:
C07D 495/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15185484

SIRTUIN ACTIVATORS AND ACTIVATION ASSAYS

IPC classification:
C12Q 1/37
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14798509

SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS

IPC classification:
C07D 471/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature